Thorne Healthtech Inc (THRN) Inventory Turnover Ratio, from second quarter 2023 to second quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Thorne Healthtech Inc   (NASDAQ: THRN)
 

Thorne Healthtech Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Thorne Healthtech Inc inventory turnover ratio, the Thorne Healthtech Inc 's ability to sell and replace its inventory in the second quarter 2023, sequentially increased to 2.03 in the second quarter 2023, a new company high. Average inventory processing period, for the Thorne Healthtech Inc in Jun 30 2023 quarter, has decreased to 180 days, compare to 183 days, in the Mar 31 2023 quarter.

Within Healthcare sector 227 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2023, to 1063, from total ranking in the first quarter 2023 at 1169.

THRN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Thorne Healthtech Inc Market Share?

What is Inventory Turnover Ratio?




THRN Inventory Turnover Ratio (Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Inventory Growth 18.54 % 20.38 % 42.99 % 61.29 % 115.46 %
Y / Y Cost of Sales Growth 29.84 % 26.12 % 41.85 % 34.58 % 23.56 %
Inventory Turnover Ratio (TTM) 2.03 2 1.98 1.95 2.02
THRN's Total Ranking # 1063 # 1169 # 1490 # 1620 # 1712
Average inventory processing period 180 183 185 187 180
Seq. Inventory Growth 18.09 % 3.51 % -3.67 % 0.67 % 19.93 %
Seq. Cost of Sales Growth 3.59 % -9.73 % 13.44 % 22.41 % 0.63 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 75
Healthcare Sector # 228
Overall Market # 1063

Inventory Turnover Ratio Statistics
High Average Low
2.03 1.93 1.63
(Jun 30 2023)   (Mar 31 2022)




Financial Statements
Thorne Healthtech Inc 's Inventories $ 72 Millions Visit THRN's Balance sheet
Thorne Healthtech Inc 's Cost of Revenues TTM $ 128 Millions Visit THRN's Income Statement
What are THRN's Sales? Visit THRN's Sales by Segment

Other Inventory Turnover Ratios
Thorne Healthtech Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
THRN's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for THRN's Competitors
Inventory Turnover Ratio for THRN's Suppliers
Inventory Turnover Ratio for THRN's Customers

You may also want to know
THRN's Sales Growth Rates THRN's Pe Price to earnings ratio THRN's Receivables Turnover Ratio THRN's Stock Quote
THRN's Net Income Growth Rates THRN's Ps Price to Sales ratio THRN's Sales per Employee THRN's Asset Turnover Ratio
THRN's Net Margin THRN's Pb Price to Book ratio THRN's Financial Strength Ratios THRN's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2023 Inventories at quarter ending Jun 30 2023
Abbvie Inc   4.76 $ 17,418.000  Millions$ 3,660  Millions
Adm Tronics Unlimited Inc   4.72 $ 1.918  Millions$ 0  Millions
Precision Optics Corporation Inc   4.70 $ 13.310  Millions$ 3  Millions
Henry Schein Inc   4.64 $ 8,744.000  Millions$ 1,886  Millions
Lifemd Inc   4.44 $ 16.068  Millions$ 4  Millions
Bristol myers Squibb Company  4.43 $ 10,388.000  Millions$ 2,346  Millions
Integrated Biopharma Inc  4.37 $ 46.000  Millions$ 11  Millions
Warby Parker Inc   4.28 $ 282.378  Millions$ 66  Millions
Organogenesis Holdings Inc   4.24 $ 106.453  Millions$ 25  Millions
Harrow Inc   4.23 $ 31.157  Millions$ 7  Millions
Catalent Inc   4.20 $ 3,223.000  Millions$ 768  Millions
T2 Biosystems Inc   4.20 $ 18.679  Millions$ 4  Millions
West Pharmaceutical Services Inc   4.11 $ 1,773.200  Millions$ 431  Millions
Steris Plc  4.10 $ 2,870.535  Millions$ 701  Millions
Neptune Wellness Solutions Inc   4.09 $ 37.567  Millions$ 9  Millions
Teva Pharmaceutical Industries Limited  4.08 $ 8,200.000  Millions$ 2,009  Millions
Moderna Inc   4.06 $ 4,541.000  Millions$ 1,118  Millions
Novocure Limited  4.04 $ 122.269  Millions$ 30  Millions
Urogen Pharma Ltd   4.03 $ 8.991  Millions$ 2  Millions
Lftd Partners Inc   4.02 $ 30.589  Millions$ 8  Millions
Escalon Medical Corp   3.95 $ 6.673  Millions$ 2  Millions
Adaptive Biotechnologies Corporation  3.86 $ 68.087  Millions$ 18  Millions
Vericel Corporation  3.76 $ 58.241  Millions$ 15  Millions
Idexx Laboratories Inc  3.74 $ 1,409.005  Millions$ 377  Millions
Envista Holdings Corporation  3.71 $ 1,109.300  Millions$ 299  Millions
Gilead Sciences Inc   3.65 $ 5,634.000  Millions$ 1,545  Millions
Endo International Plc  3.64 $ 1,022.092  Millions$ 281  Millions
Caredx Inc   3.62 $ 67.048  Millions$ 19  Millions
Twist Bioscience Corporation  3.61 $ 144.542  Millions$ 40  Millions
Cadre Holdings inc   3.60 $ 278.061  Millions$ 77  Millions

Date modified: 2026-08-29T17:45:27+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.